aboutpersonalized diagnostic servicespatient resourcesclient loungebiopharm servicesinvestorscareers
Genoptix Home
Fundamentals - Snapshot

Snapshot | Trading Statistics | Balance Sheet | Income Statement | Cash Flow | Ratios
Revenue & Earnings
Revenue (FY)184.38
EBIT (Mil) (FY)53.81
EBITDA (Mil) (FY)57.61
Net Income Excluding Extraordinary Items (Mil) (FY)30.63
Net Income Including Extraordinary Items (Mil) (FY)30.63
Diluted EPS Excluding Extraordinary Items (FY)1.71
Diluted EPS Including Extraordinary Items (FY)1.71
Dividends
Yield (%)--
Dividend Record Date--
Dividend Rate--
Ratios
Price to Revenue (TTM)1.59
Price To Cash Flow (TTM)9.98
Price to Book (MRQ)1.57
Total Debt to Equity (MRQ) (%)--
Current Ratio (MRQ)7.32
Growth
5-Year Annual Dividend Growth Rate (%)--
5-Year Annual Revenue Growth Rate (%)202.33
FY = Fiscal Year MRQ = Most Recent Quarter
mil = Millions TTM = Trailing Twelve Months
Powered by Thomson Reuters

investors

company information • corporate profile

news and events• news releases• upcoming events• webcasts & presentations

financial information • fundamentals• quarterly results• annual reports• sec filings• reconciliation & supplemental material

stock information• stock quote & charts• historical prices • investment calculator• analyst coverage• proxy information

corporate governance• board of directors• executive officers• committee composition

shareholder information• ir contacts• information request• online investor kit• email alerts• faqs

© 2010 Genoptix, Inc. All rights reserved. Home | eCOMPASS Login | Contact | Terms of Use | Privacy | Site Map